The must attend healthcare conferences in Winter/Spring 2025
Where has the time gone? We are now in 2025, and industry events are quickly approaching.
If you are still gathering your thoughts on how best to maximise your events calendar this year, allow us to flag some of the ‘must-attend’ Healthcare conferences of Winter/Spring 2025.
January is for JPM
The 43rd JPM Annual Healthcare Conference: 13th-16th January, San Francisco, CA
This premier conference is the largest and most informative healthcare investment symposium in the industry, connecting global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. Learn how the latest advances, leading research and best practices are being applied.
The Optimum Team will be in San Francisco, so please reach out if you would like to connect there.
Off to a flying start for Feb
BioCapital Europe: 5th-6th February, Amsterdam, The Netherlands
Offering VCs and institutional investors unique and timely access to around 40 exciting biotech, medtech and diagnostics companies from the Benelux and Europe – make sure you don’t miss out on BioCapital 2025.
March’ing on
LSX RNA Leaders Europe Congress: 5th-6th March, Basel, Switzerland
RNA chemistry is a hot area in the life sciences industry and LSX RNA Leaders brings together the best in the sector to hear the latest advances, get clinical updates from the companies developing new therapies, and source the partners who are helping to deliver drugs to patients.
Make a 15% saving for all LSX 2025 European events by using Optimum’s exclusive discount. Please reach out to the team if you would like to make use of this!
Bio-Europe Spring: 17th-19th March, Milan, Italy
Bio-Europe Spring connects Europe’s top innovators with the global life science industry, showcasing the latest innovations which will advance the treatments of tomorrow.
Take advantage of the early bird discount and save up to €700 by registering before the 31st January!
Action stations April
OBN BioTrinity: 1st-2nd April, London, UK
BioTrinity is OBN’s flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The delegate mix comprises early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.
As a proud investor relations partner, the Optimum team will be in attendance. Please do reach out if you would like to connect with us there.
21st Anglonordic Life Science Conference 2025: 3rd April, London, UK
Optimum is once again proud to program the Anglonordic Life Sciences Conference agenda in 2025.
With an exciting day of speakers and networking, the conference brings together exclusively selected attendees composed of the C-suite of emerging life science companies from across Europe and the UK, decision-makers from key investor firms, Pharma companies, and key supporters of the European life science ecosystem.
Göran Ando MD, has been announced as the keynote speaker. Retired chair of Novo Nordisk A/S and currently chairman of Eyepoint Pharmaceuticals, Nouscom, and Nanexa AB, Göran brings 45 years of industry experience.
Use our partnering discount and receive a wonderful 20% off the ticketed price.
11th LSX World Congress: 28th-30th April, London, UK
LSX World Congress brings together the CEOs and senior decision makers from the world’s most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs.
Together, they share best practice, forge partnerships and investments – all aimed at putting capital and ideas to work to help create the world’s future medicines and improve patient outcomes. Take advantage of Optimum’s 15% discount and put LSX World Congress in your Spring 2025 calendar.
May the sun shine
BioEquity: 12th-14th May, Bruges, Belgium
Head off to Bruges in May for Bioequity, where the event connects CEOs and investors to network, partner, and debate critical issues facing the biotech industry today.
